title: Pegaptanib octasodium for the treatment of diabetic macular edema.
authors.affiliation: Retina Associates of Cleveland, OH, USA.
authors.forename: Jerome P
authors.initials: JP
authors.lastname: Schartman
authors.forename: Joseph M
authors.initials: JM
authors.lastname: Coney
authors.forename: Joan H
authors.initials: JH
authors.lastname: Hornik
authors.forename: David G
authors.initials: DG
authors.lastname: Miller
mesh_terms: D052157:Aptamers, Nucleotide / Q000627:therapeutic use*; D017322:Clinical Trials, Phase II as Topic; D003930:Diabetic Retinopathy / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D008269:Macular Edema / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*
chemical_list: D052157:Aptamers, Nucleotide; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; C495058:pegaptanib